Effect of Canagliflozin Treatment on Hepatic Triglyceride Content and Glucose Metabolism in Patients with Type 2 Diabetes

CONCLUSIONSCanagliflozin improves hepatic insulin sensitivity and insulin secretion and clearance in patients with T2DM. IHTG decreases in proportion to the magnitude of weight loss, which tended to be greater and occur more often with canagliflozin.This article is protected by copyright. All rights reserved.

https://onlinelibrary.wiley.com/doi/abs/10.1111/dom.13584?af=R

Source: Diabetes, Obesity and Metabolism - November 16, 2018 Category: Endocrinology Authors: Kenneth Cusi, Fernando Bril, Diana Barb, David Polidori, Sue Sha, Atalanta Ghosh, Kristin Farrell, Nishanth E. Sunny, Srilaxmi Kalavalapalli, Jeremy Pettus, Theodore P. Ciaraldi, Sunder Mudaliar, Robert R. Henry Tags: ORIGINAL ARTICLE Source Type: research